Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Shigella (bivalent) vaccine by Chongqing Zhifei Biological Products for Bacillary Dysentery (Shigellosis): Likelihood of Approval
Shigella (bivalent) vaccine is under clinical development by Chongqing Zhifei Biological Products and currently in Phase III for Bacillary Dysentery...